For years, the mechanism behind VITT cast a shadow over adenoviral vector vaccines — a technology that has otherwise been central to global immunisation efforts. A new study has provided a clear molecular explanation by identifying a particular protein to be the trigger and defining the precise antibody features involved

Source: The Hindu